Hyperfine (NASDAQ:HYPR - Get Free Report) is expected to be releasing its earnings data after the market closes on Monday, March 17th. Analysts expect Hyperfine to post earnings of ($0.16) per share and revenue of $2.30 million for the quarter. Persons that are interested in registering for the company's earnings conference call can do so using this link.
Hyperfine Trading Down 3.3 %
HYPR traded down $0.03 on Thursday, hitting $0.94. 76,137 shares of the company's stock traded hands, compared to its average volume of 392,662. The firm has a market cap of $68.35 million, a price-to-earnings ratio of -1.64 and a beta of 0.94. The company's 50 day simple moving average is $1.07 and its 200-day simple moving average is $1.01. Hyperfine has a one year low of $0.76 and a one year high of $1.90.
Hyperfine Company Profile
(
Get Free Report)
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Read More
Before you consider Hyperfine, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperfine wasn't on the list.
While Hyperfine currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
